Frederick Albert Schroeder

Title: The Innovations of Frederick Albert Schroeder

Introduction

Frederick Albert Schroeder is a notable inventor based in Baltimore, MA (US). He has made significant contributions to the field of medical imaging, particularly in the development of histone deacetylase imaging agents. With a total of 3 patents, his work has the potential to advance diagnostic techniques in healthcare.

Latest Patents

One of his latest patents focuses on "Imaging histone deacetylases with a radiotracer using positron emission tomography." This patent discloses histone deacetylase imaging agents designed for positron emission tomography and outlines related imaging methods. The agents may include a compound of formula (I), where R is a moiety that includes a positron emitter, and R can represent hydrogen, or substituted or unsubstituted alkyl, aryl, or heteroaryl. In one version of the compound, R features an adamantyl group, showcasing the innovative approach taken by Schroeder in this field.

Career Highlights

Frederick Albert Schroeder is currently associated with The General Hospital Corporation, where he continues to push the boundaries of medical imaging technology. His work is instrumental in enhancing the understanding of histone deacetylases, which play a crucial role in various biological processes and diseases.

Collaborations

Throughout his career, Schroeder has collaborated with esteemed colleagues such as Jacob Matthew Hooker and Changning Wang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Frederick Albert Schroeder's contributions to the field of medical imaging through his patents and collaborations highlight his role as a significant inventor. His work not only advances scientific knowledge but also has the potential to improve patient care through enhanced diagnostic methods.